Patent US5355719A successfully refreshed from Google Patents.
Patent US2812323A successfully refreshed from Google Patents.
← Back to Patent Explorer
US2812323A Expired / Lapsed US ⏱️ 0.0 years remaining

Des-n-methyl erythromycin

Assignee: Eli Lilly and Co
•
Filing: 1954-11-03
•
Granted: 1957-11-05
•
Expires: 1974-11-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Edwin H Flynn
  • 👤 Hubert W Murphy

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 07:21
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/08

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 62 words
THE PROCESS OF PREPARING DES-N-METHYL ERYTHROMYCIN WHICH COMPRISES REACTING ERYTHROMYCIN WITH AT LEAST TWO MOLAR EQUIVALENTS OF BENZYL CHLOROCARBONATE IN THE PRESENCE OF A SOLID BASE AT A TEMPERATURE UNDER ABOUT 70*C. TO FORM DES-N-METHYL ERYTHROMYCIN BENZYL CARBONATE BENZYL CARBAMATE AND THEN REMOVING THE BENZYL CARBONYL GROUPS BY HYDROGENATION IN THE PRESENCE OF A NOBLE METAL HYDROGENATION CATALYST TO PRODUCE DES-NMETHYL ERYTHROMYCIN.
Claim 2
Dependent Claim 62 words
THE PROCESS OF PREPARING DES-N-METHYL ERYTHROMYCIN WHICH COMPRISES REACTING ERYTHROMYCIN WITH AT LEAST TWO MOLAR EQUIVALENTS OF BENZYL CHLOROCARBONATE IN THE PRESENCE OF A SOLID BASE AT A TEMPERATURE UNDER ABOUT 70*C. TO FORM DES-N-METHYL ERYTHROMYCIN BENZYL CARBONATE BENZYL CARBAMATE AND THEN REMOVING THE BENZYL CARBONYL GROUPS BY HYDROGENATION IN THE PRESENCE OF A NOBLE METAL HYDROGENATION CATALYST TO PRODUCE DES-NMETHYL ERYTHROMYCIN.
Claim 3
Dependent Claim 30 words
THE PROCESS WHICH COMPRISES SUBJECTING DES-NMETHYL ERYTHROMYCIN BENZYL CARBONATE BENZYL CARBAMATE TO HYDROGENOLYSIS IN INERT SOLVENT SOLUTION IN THE PRESENCE OF A NOBLE METAL HYDROGENATION CATALYST THUS FORMING DES-N-METHYL ERYTHROMYCIN.
Claim 4
Dependent Claim 30 words
THE PROCESS WHICH COMPRISES SUBJECTING DES-NMETHYL ERYTHROMYCIN BENZYL CARBONATE BENZYL CARBAMATE TO HYDROGENOLYSIS IN INERT SOLVENT SOLUTION IN THE PRESENCE OF A NOBLE METAL HYDROGENATION CATALYST THUS FORMING DES-N-METHYL ERYTHROMYCIN.
Claim 5
Dependent Claim 6 words
DES-N-METHYL ERYTHROMYCIN BENZYL CARBONATE BENZYL CARBAMATE.
Claim 6
Dependent Claim 6 words
DES-N-METHYL ERYTHROMYCIN BENZYL CARBONATE BENZYL CARBAMATE.

References Cited (Backward Citations)

CA506308A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1960-11-04 1961-05-06 1961-11-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1964-11-04 1965-05-06 1965-11-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1968-11-04 1969-05-06 1969-11-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag